fda_approval · anda · info
SAPTALIS PHARMS — ANDA approval: TOFACITINIB CITRATE (unspecified)
- Event date
- 2026-06-09 00:00:00Z
- Observed
- 2026-07-09 22:53:25Z
- Source ID
- ANDA218900-1
- Payload hash
- 49ab4a1d15b32ebf4f28e542…
Summary
SAPTALIS PHARMS received ANDA approval for TOFACITINIB CITRATE (unspecified) on 2026-06-09. Dosage form: SOLUTION. Application #: ANDA218900.
Entities
Informational only. Not legal, financial, or medical advice.